|4Feb 9, 8:01 PM ET

BURGER DENIS R 4

4 · CytoDyn Inc. · Filed Feb 9, 2018

Insider Transaction Report

Form 4
Period: 2018-02-07
Transactions
  • Award

    Stock Options (right to buy)

    2018-02-07+80,33180,331 total
    Exercise: $0.56From: 2018-02-07Exp: 2028-02-07Common Stock (80,331 underlying)
Footnotes (1)
  • [F1]On February 7, 2018, the board of directors of CytoDyn Inc. approved an amendment to its director compensation program, providing for payment in stock options, in lieu of cash, of all unpaid director retainer fees for the four-quarter period ending February 28, 2018. The number of options awarded to each director was determined by applying a price of $0.31 per option, which was the fair value estimate of the option award as of the grant date, using the Black-Scholes option pricing model.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION